Recombinant DNA Advisory Committee - 12/3-4/92 
Debra Wilson, OD 
Louise Williams, NHLBI 
Jeehong Yoo, NHLBI 
Others: 
Paul Aebersold, Food and Drug Administration 
French Anderson, University of Southern California 
James Barrett, Genetic Therapy, Inc. 
Robert Beall, Cystic Fibrosis Foundation 
John Bishop, Food and Drug Administration 
Hal Broderson, Hilman Medical 
Richard Boucher, University of North Carolina 
Anthony Calandra, Amgen 
Barrie Carter, Targeted Genetics, Inc. 
Gwladys Caspar, Harvard University 
Yawen Chiang, Genetic Therapy, Inc. 
Jan Chappell, Genetic Therapy, Inc. 
Ed Chen, Los Angeles Times 
Larry Cohen, Somatix Therapy 
Francis Collins, University of Michigan 
Declan Conroy, Biotech Daily 
Matt Cotten, Institute for Molecular Pathology 
Mike Courtney, Transgene, Inc. 
Andrew Cuthbertson, Genentech 
Ann Daigle, Immune Response, Inc. 
Kevin Davies, Nature Genetics 
Brian Davis, Medicines Control Agency 
Albert Deisseroth, MD Anderson Cancer Research Center 
Ronald Dorazio, Columbia University 
Lori Doyle, University of Pennsylvania Medical Center 
Anne Driscoll, Fox, Bennett and Turner 
William Egan, Food and Drug Administration 
John Engel, University of Michigan 
Suzanne Epstein, Food and Drug Administration 
Carol Ezzell, Science News 
Susan Falen, Genetic Therapy, Inc. 
Mitchell Finer, Cell Genesys, Inc. 
Mark Fischetti, Freelance Writer 
Stacy Fitzsimmons, Cystic Fibrosis Foundation 
Terry Flotte, Johns Hopkins Hospital 
Bernard Fox, University of Michigan 
[534] 
Recombinant DNA Research, Volume 16 
